MBX:TSX, Microbix Biosystems Inc.

MBX stock overview

Microbix Biosystems Inc. (MBX:TSX) closed at $0.285 on November 6, 2026, down 1.72% on the day. The stock trades 13.6% below its 52-week high of $0.330 and 35.7% above its 52-week low of $0.210. Over the past year, it gained 14.0%. Microbix Biosystems Inc. is part of the Life Sciences sector (Biotechnology).

Key figures

Price
$0.285
Day change
-1.72%
Volume
33,400
Average volume
28,942
Market cap
39M+
52-week range
$0.210 – $0.330
50-day average
$0.305
200-day average
$0.274

Price action over the past year

In 252 trading sessions since November 6, 2025, MBX closed higher on 65 days (26%). Its best day was March 10, 2026 (+13.04%) and its worst was December 18, 2025 (-12.50%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

MBX news

About Microbix Biosystems Inc.

Microbix Biosystems Inc develops biological products and technologies. The Company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort.

Similar stocks

Find more stocks like MBX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.